<html><body><h2>Case: 1494845</h2><h3> CDS Time: 1970-11-05</h3>
<patient name=1494845>
70.0 year old White_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">70</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">43</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Calcium</td><td width="200">9</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">43</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">162</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Chloride</td><td width="200">101.0</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">65</td><td width="200">1970-11-5</td></tr>
<tr><td width="200">Weight</td><td width="200">226</td><td width="200">1970-11-5</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1968-4-11</td></tr>
<tr><td width="200">Urine_ALB/CREAT_RATIO_spot</td><td width="200">46</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Urine_Alb/creat_Ratio_24h</td><td width="200">46</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">SGOT</td><td width="200">21</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">124</td><td width="200">1970-11-5</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">2</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">Height</td><td width="200">72</td><td width="200">1970-11-2</td></tr>
<tr><td width="200">Potassium</td><td width="200">5</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">BUN</td><td width="200">48</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">HCT</td><td width="200">30</td><td width="200">1970-10-9</td></tr>
<tr><td width="200">HGB</td><td width="200">10</td><td width="200">1970-10-9</td></tr>
<tr><td width="200">Sodium</td><td width="200">136</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.7</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">UrineAlbumin_24H</td><td width="200">65</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1968-4-11</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">43.0</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">43</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">UrineAlbumin_SPOT</td><td width="200">65</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Pulse</td><td width="200">59</td><td width="200">1970-11-5</td></tr>
<tr><td width="200">PLT</td><td width="200">91</td><td width="200">1970-10-9</td></tr>
<tr><td width="200">WBC</td><td width="200">6</td><td width="200">1970-10-9</td></tr>
<tr><td width="200">eGFR</td><td width="200">53</td><td width="200">1970-2-8</td></tr>
<tr><td width="200">SGPT</td><td width="200">32</td><td width="200">1970-10-8</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1970-10-9</td></tr>
<tr><td width="200">Uric_Acid</td><td width="200">Moderate</td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1970-1-27</td></tr>
<tr><td width="200">Cardiomyopathy</td><td width="200"></td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1970-10-8</td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1970-9-7</td></tr>
<tr><td width="200">Bronchospastic_Disease</td><td width="200"></td><td width="200">1970-10-9</td></tr>
<tr><td width="200">Pacemaker</td><td width="200"></td><td width="200">1969-8-25</td></tr>
<tr><td width="200">Liver_Disease</td><td width="200"></td><td width="200">1970-10-25</td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1970-1-27</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1970-9-24</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1970-11-2</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1970-10-9</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1970-11-5</td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) glyburide(2.5) spironolactone(50.0) Insulin(2.0) metformin(500.0) torsemide(40.0) atorvastatin(80.0) carvedilol(12.5) digoxin(0.25) eplerenone(50.0) hydralazine(30.0) hydrochlorothiazide(25.0) valsartan(40.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">CRI</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(1.7/1970-10-8) && Sex(Male) && Creatinine(1.7/1970-10-8)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">DM (2ary prev)  BP controlled</td>
<td width="200"></td>
<td width="200"> Diabetes (Secondary Prevention)[Treatment_Diastolic_BP(65/null) && Treatment_Systolic_BP(124/null) && presence of diabetes mellitus]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(65/null) && Treatment_Systolic_BP(124/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(65/null) && Treatment_Systolic_BP(124/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Age(70.0/1970-1-1) && Sex(Male)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of lipid disorder ICD9]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(53.0/1970-2-8)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(53.0/1970-2-8)]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(70.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Active prescription for ARB and aldosterone antagonist</td>
<td width="200"></td>
<td width="200"> Active prescription for ARB and aldosterone antagonist[Presence of ARB && presence of aldosterone antagonist]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Most recent K>=5</td>
<td width="200"></td>
<td width="200"> Most recent K>=5[Potassium(5.1/1970-10-8)]()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200">1970-10-25</td>
<td width="200"> Liver_Disease()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1970-11-02</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1970-09-24</td>
<td width="200"> Cardiomyopathy()</td></tr>
<tr> <td width="200"></td>
<td width="200">1970-09-07</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1970-10-08</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1970-09-24</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Pacemaker</td>
<td width="200">1969-08-25</td>
<td width="200"> Pacemaker()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1970-01-27</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1970-10-09</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200">Respiratory_Diseases</td>
<td width="200">1970-10-09</td>
<td width="200"> Bronchospastic_Disease()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1970-01-27</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1970-11-05</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200">1970-09-24</td>
<td width="200"> Uric_Acid()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
<p><b>Allergies and Adverse Reactions:</b> <ul>
<li>Substance: spironolactone Reaction: 
<li>Substance: spironolactone Reaction: 
 </ul>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> unknown(LDL_Cholesterol(no value))
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(65/null) && Treatment_Systolic_BP(124/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>aldosterone antagonist<ul><li>Already being used<li>Contraindications:  Most recent K>=5(Most recent K>=5[Potassium(5.1/1970-10-8)]) <li>Adverse events:  (aldosterone antagonist)  (aldosterone antagonist) <li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>Beta Blocker Stage B no MI<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Enalapril)<ul><li>Relative contraindications:  Active prescription for ARB and aldosterone antagonist(Active prescription for ARB and aldosterone antagonist[Presence of ARB && presence of aldosterone antagonist]) <li>preference: neutral</ul><li>ARB<ul><li>Already being used<li>preference: ruled out</ul><li>digoxin<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomyopathy, Cardiomegaly, Heart_Failure) <li>preference: ruled out</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>Already being used<li>preference: ruled out</ul></ul></body></html>